SCHEMBL5031049

SCHEMBL5031049

[SiH3]CC(OC1CCCCC1)(OC1CCCCC1)OC1CCCCC1

nearest known ligand 0.31

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.31
CYP2C19 P33261 1/20 0.31
CA1 P00915 1/20 0.30
CA2 P00918 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28700603 0.73 NPC1 (0.39) NPC1
SCHEMBL28449701 0.72
SCHEMBL5031087 0.70 CA1 (0.33) NPC1CA1CA2
SCHEMBL28713054 0.70 NPC1 (0.35) NPC1
SCHEMBL28963148 0.69 CA1 (0.36) NPC1CA1CA2
SCHEMBL28962625 0.66 CA1 (0.32) CA1CA2
SCHEMBL5031045 0.65 NPC1 (0.36) NPC1
SCHEMBL1683314 0.65 CA1 (0.33) NPC1CA1CA2
SCHEMBL9813280 0.65 CA1 (0.33) NPC1CA1CA2
SCHEMBL9623348 0.65 CA1 (0.33) NPC1CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1999167-A2 ZIEGLER-NATTA CATALYST WITH IN SITU-GENERATED DONOR Novolen Technology Holdings, C.V. (NL) 2008-12-10 EP disclosed
WO-2007106348-A2 ZIEGLER-NATTA CATALYST WITH IN SITU-GENERATED DONOR NOVOLEN TECHNOLOGY HOLDINGS C.V. (NL) 2007-09-20 WO disclosed
US-20070213204-A1 Ziegler-Natta catalyst with in situ-generated donor NOVOLEN TECHNOLOGY HOLDINGS C.V. 2007-09-13 US disclosed